(10 Tests) Point-of-Care Testing for Acute Conjunctivitis Acute conjunctivitis – more commonly known as “pink eye” – affects nearly 6.9 million people in the United States every year.1 Approximately 1 in 4 patients with acute conjunctivitis have confirmed adenoviral conjunctivitis.2,3 AdenoPlus is the first and only CLIA-waived, point-of-care test that detects all known serotypes of adenoviral conjunctivitis.
- Isolate and manage contagious patients
- Prevent the spread of infection
- Reduce unnecessary antibiotic prescriptions
- Reduce potential ocular allergies and toxicities associated with unnecessary antibiotic use
- Help prevent antibiotic resistance
